Skip to main content
Precision BioSciences, Inc. (DTIL)
NASDAQ: DTIL · IEX Real-Time Price · USD
9.41
-0.48 (-4.85%)
At close: Jul 2, 2024, 4:00 PM
9.81
+0.40 (4.22%)
After-hours: Jul 2, 2024, 5:51 PM EDT

Precision BioSciences Revenue

Precision BioSciences had revenue of $57.53M in the twelve months ending March 31, 2024, with 88.25% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $17.58M with 100.27% year-over-year growth. In the year 2023, Precision BioSciences had annual revenue of $48.73M with 94.15% growth.

Revenue (ttm)
$57.53M
Revenue Growth
+88.25%
P/S Ratio
1.13
Revenue / Employee
$527,807
Employees
109
Market Cap
65.17M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202348.73M23.63M94.15%
Dec 31, 202225.10M-90.43M-78.28%
Dec 31, 2021115.53M91.24M375.72%
Dec 31, 202024.29M2.05M9.20%
Dec 31, 201922.24M11.36M104.34%
Dec 31, 201810.88M4.40M67.84%
Dec 31, 20176.48M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

DTIL News

More News